Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infectionsInt J Antimicrob Agents 2014;44:16–25.

Bass JW, Freitas BC, Freitas AD, Sisler CL, Chan DS, Vincent JM, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. 1998 Jun;17(6):447–52.

Chamberlin J, Laughlin LW, Romero S, Solorzano N, Gordon S, Andre RG, et al. Epidemiology of endemic Bartonella bacilliformis: a prospective cohort study in a Peruvian mountain valley community. J Infect Dis. 2002 Oct 1;186(7):983–90.

Chi SL, Stinnett S, Eggenberger E, Foroozan R, Golnik K, Lee MS, Bhatti MT. Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology. 2012 Jan;119(1):183-7. Epub 2011 Sep 28.

Dolan MJ, Wong MT, Regnery RL, Jorgensen JH, Garcia M, Peters J, Drehner D. Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med. 1993 Mar 1;118(5):331-6.

Florin TA, Zaoutis TE, Zaoutis, LB. Beyond cat scratch disease: Widening spectrum of Bartonella henselae infection. Pediatrics 2008 Apr 28;121(5):1413-25.

Foucalt C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis. 2006 Feb;12(2) 217-23.

Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010 Jul 15;51(2):131–40.

Guptill L, Wu CC, HogenEsch H, Slater LN, Glickman N, Dunham A, et al. Prevalence, risk factors, and genetic diversity of Bartonella henselae infections in pet cats in four regions of the United States. J Clin Microbiol. 2004 Feb;42(2):652–9.

Kaiser PO, Riess T, O’Rourke F, Linke D, Kempf VA. Bartonella spp.: throwing light on uncommon human infections. Int J Med Microbiol. 2011 Jan;301(1):7-15.

Koehler JE, Sanchez MA, Garrido CS, Whitfeld MJ, Chen FM, Berger TG, Rodriguez-Barradas MC, LeBoit PE, Tappero JW. Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med. 1997 Dec 25;337(26):1876-83.

Maguiña C, Gotuzzo E. Bartonellosis. New and old. Infect Dis Clin North Am. 2000 Mar;14(1):1–22, vii.

McCormick DW, Rassoulian-Barrett SL, Hoogestraat DR, Salipante SJ, SenGupta D, Dietrich EA, et al. Bartonella spp. Infections identified by molecular methods, United States. Emerg Infect Dis. 2023 Mar;29(3):467-476.

Nawrocki CC, Max RJ, Marzec NS, Nelson CA. Atypical manifestations of cat-scratch disease, United States, 2005-2014. Emerg Infect Dis. 2020 Jun;26(7):1438-1446.

Nelson CA, Moore AR, Perea AE, Mead PS. Cat scratch disease: U.S. clinicians’ experience and knowledge. Zoonoses Public Health. 2018;65:67-73.

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of Bartonellosis. Recommendations from the Centers for Disease Control and Prevention, the National Institutesof Health, and the HIV Medicine Association of the Infectious Diseases Society of America. [PDF – 6 pages]

Regnery RL, Olson JG, Perkins BA, Bibb W. Serological response to “Rochalimaea henselae” antigen in suspected cat-scratch disease. Lancet. 1992 Jun 13;339(8807):1443-5.

Reynolds MG, Holman RC, Curns AT, et al. Epidemiology of cat-scratch disease hospitalizations among children in the United States. Pediatr Infect Dis J 2005;24:700-4.

Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004 Jun;48(6):1921-33.

Schultz MG. Who is this man? [PDF – 3 pages] Emerg Infect Dis. 2010. June;16(6):1025-7.

Telford SR and Wormser GP. Bartonella spp. transmission by ticks not established. Emerg Infect Dis. 2010 Mar;16(3) 379-84.